UBS Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-422,178
| Closed | -$134M | – | 8876 |
|
|
2023
Q4 | $134M | Buy |
422,178
+419,217
| +14,158% | +$133M | 0.04% | 342 |
|
|
2023
Q3 | $501K | Sell |
2,961
-13,555
| -82% | -$2.29M | ﹤0.01% | 3602 |
|
|
2023
Q2 | $3.58M | Sell |
16,516
-8,750
| -35% | -$1.9M | ﹤0.01% | 2174 |
|
|
2023
Q1 | $4.59M | Buy |
25,266
+889
| +4% | +$161K | ﹤0.01% | 1910 |
|
|
2022
Q4 | $4.79M | Buy |
24,377
+20,672
| +558% | +$4.06M | ﹤0.01% | 1868 |
|
|
2022
Q3 | $833K | Sell |
3,705
-6,234
| -63% | -$1.4M | ﹤0.01% | 2995 |
|
|
2022
Q2 | $1.26M | Sell |
9,939
-20,061
| -67% | -$2.54M | ﹤0.01% | 2713 |
|
|
2022
Q1 | $3.8M | Buy |
30,000
+28,242
| +1,606% | +$3.58M | ﹤0.01% | 2146 |
|
|
2021
Q4 | $230K | Sell |
1,758
-21,949
| -93% | -$2.87M | ﹤0.01% | 4532 |
|
|
2021
Q3 | $2.9M | Buy |
23,707
+23,096
| +3,780% | +$2.83M | ﹤0.01% | 2465 |
|
|
2021
Q2 | $70K | Sell |
611
-4,378
| -88% | -$502K | ﹤0.01% | 5094 |
|
|
2021
Q1 | $600K | Buy |
4,989
+4,285
| +609% | +$515K | ﹤0.01% | 3802 |
|
|
2020
Q4 | $72K | Sell |
704
-76
| -10% | -$7.77K | ﹤0.01% | 4926 |
|
|
2020
Q3 | $61K | Sell |
780
-1,644
| -68% | -$129K | ﹤0.01% | 4659 |
|
|
2020
Q2 | $271K | Buy |
2,424
+366
| +18% | +$40.9K | ﹤0.01% | 3804 |
|
|
2020
Q1 | $149K | Sell |
2,058
-904
| -31% | -$65.5K | ﹤0.01% | 4114 |
|
|
2019
Q4 | $223K | Sell |
2,962
-536
| -15% | -$40.4K | ﹤0.01% | 4536 |
|
|
2019
Q3 | $57K | Buy |
+3,498
| New | +$57K | ﹤0.01% | 5193 |
|